Feasibility Study: Evaluation of the Ulthera® System for Treatment of the Knees
1 other identifier
interventional
30
1 country
1
Brief Summary
Enrolled subjects will receive one bilateral Ulthera® treatment on the knees. Up to 30 subjects will be enrolled. Study photos will be obtained prior to study treatment, immediately following study treatment, and at each post-treatment follow-up visit. Follow-up visits will occur at 90 and 180 days post-treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
October 15, 2012
CompletedFirst Posted
Study publicly available on registry
October 17, 2012
CompletedNovember 24, 2017
June 1, 2013
11 months
October 15, 2012
November 21, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improvement in overall lifting and tightening of knee skin laxity.
Assessed based on Principal Investigator assessment using the Global Aesthetic Improvement Scale.
90 and 180 days post-treatment
Secondary Outcomes (1)
Overall improvement in skin laxity.
90 and 180 days post-treatment
Study Arms (1)
Ulthera® treatment of the knees
EXPERIMENTALBilateral treatment of the knees using the Ulthera® System
Interventions
Focused ultrasound energy delivered below the surface of the skin
Eligibility Criteria
You may qualify if:
- Female, aged 30 to 65 years.
- Subject in good health.
- Mild to moderate skin laxity around the knees.
- Understands and accepts the obligation not to undergo any other procedures in the areas to be treated through the follow-up period.
You may not qualify if:
- Presence of an active systemic or local skin disease that may affect wound healing.
- Excessive subcutaneous fat around the knees.
- Excessive skin laxity around the knees.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ulthera, Inclead
Study Sites (1)
Tennessee Clinical Research Center
Nashville, Tennessee, 37215, United States
Related Publications (1)
Gold MH, Sensing W, Biron J. Use of micro-focused ultrasound with visualization to lift and tighten lax knee skin (1.). J Cosmet Laser Ther. 2014 Oct;16(5):225-9. doi: 10.3109/14764172.2014.949273. Epub 2014 Sep 2.
PMID: 25065380DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Gold, MD
Tennessee Clinical Research Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 15, 2012
First Posted
October 17, 2012
Study Start
June 1, 2011
Primary Completion
May 1, 2012
Study Completion
August 1, 2012
Last Updated
November 24, 2017
Record last verified: 2013-06